Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.420
+0.080 (5.97%)
At close: Oct 28, 2025, 4:00 PM EDT
1.400
-0.020 (-1.41%)
After-hours: Oct 28, 2025, 7:39 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $8.27 million as of October 28, 2025. Its market cap has decreased by -40.05% in one year.
Market Cap
8.27M
Enterprise Value
-8.67M
1-Year Change
-40.05%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $8.27M, a decrease of -56.31%. That is a compound annual growth rate of -21.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 7.81M | -56.35% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |